De Meerleer G - Search Results

1

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Muir K, Lophatananon A, Wan P, Le Marchand L, Wilkens LR, Stevens VL, Gapstur SM, Carter BD, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Giles GG, Southey MC, MacInnis RJ, Cybulski C, Wokołorczyk D, Lubiński J, Neal DE, Donovan JL, Hamdy FC, Martin RM, Nordestgaard BG, Nielsen SF, Weischer M, Bojesen SE, Røder MA, Iversen P, Batra J, Chambers S, Moya L, Horvath L, Clements JA, Tilley W, Risbridger GP, Gronberg H, Aly M, Szulkin R, Eklund M, Nordström T, Pashayan N, Dunning AM, Ghoussaini M, Travis RC, Key TJ, Riboli E, Park JY, Sellers TA, Lin HY, Albanes D, Weinstein SJ, Mucci LA, Giovannucci E, Lindstrom S, Kraft P, Hunter DJ, Penney KL, Turman C, Tangen CM, Goodman PJ, Thompson IM Jr, Hamilton RJ, Fleshner NE, Finelli A, Parent MÉ, Stanford JL, Ostrander EA, Geybels MS, Koutros S, Freeman LEB, Stampfer M, Wolk A, Håkansson N, Andriole GL, Hoover RN, Machiela MJ, Sørensen KD, Borre M, Blot WJ, Zheng W, Yeboah ED, Mensah JE, Lu YJ, Zhang HW, Feng N, Mao X, Wu Y, Zhao SC, Sun Z, Thibodeau SN, M… See abstract for full author list ➔ Conti DV, et al. Among authors: de ruyck k, de meerleer g. Nat Genet. 2021 Jan;53(1):65-75. doi: 10.1038/s41588-020-00748-0. Epub 2021 Jan 4. Nat Genet. 2021. PMID: 33398198 Free PMC article.

2

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

De Meerleer G, Fonteyne V, Meersschout S, Van den Broecke C, Villeirs G, Lumen N, Ost P, Vandecasteele K, De Neve W. De Meerleer G, et al. Among authors: de neve w. Radiother Oncol. 2008 Nov;89(2):205-13. doi: 10.1016/j.radonc.2008.07.027. Epub 2008 Sep 2. Radiother Oncol. 2008. PMID: 18771809

3

Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Ost P, Fonteyne V, Villeirs G, Lumen N, Oosterlinck W, De Meerleer G. Ost P, et al. Among authors: de meerleer g. Eur Urol. 2009 Oct;56(4):669-75. doi: 10.1016/j.eururo.2009.05.041. Epub 2009 May 29. Eur Urol. 2009. PMID: 19501453

4

Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy.

Ost P, De Meerleer G, De Gersem W, Impens A, De Neve W. Ost P, et al. Among authors: de gersem w, de meerleer g, de neve w. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):188-94. doi: 10.1016/j.ijrobp.2009.10.029. Epub 2010 Apr 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20378272

5

Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperberg, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30.

Ost P, Bossi A, De Meerleer G. Ost P, et al. Among authors: de meerleer g. Eur Urol. 2010 Sep;58(3):e33; author reply e34-5. doi: 10.1016/j.eururo.2010.05.006. Epub 2010 May 20. Eur Urol. 2010. PMID: 20537787 No abstract available.

6

Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.

Ost P, Speleers B, De Meerleer G, De Neve W, Fonteyne V, Villeirs G, De Gersem W. Ost P, et al. Among authors: de gersem w, de meerleer g, de neve w. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):920-6. doi: 10.1016/j.ijrobp.2010.04.025. Epub 2010 Aug 2. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675077

7

A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.

Ost P, De Troyer B, Fonteyne V, Oosterlinck W, De Meerleer G. Ost P, et al. Among authors: de meerleer g, de troyer b. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1316-22. doi: 10.1016/j.ijrobp.2010.04.039. Epub 2010 Aug 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675081

8

A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer.

Ost P, De Gersem W, De Potter B, Fonteyne V, De Neve W, De Meerleer G. Ost P, et al. Among authors: de potter b, de gersem w, de meerleer g, de neve w. Clin Oncol (R Coll Radiol). 2011 Jun;23(5):344-9. doi: 10.1016/j.clon.2011.01.505. Epub 2011 Feb 24. Clin Oncol (R Coll Radiol). 2011. PMID: 21353504

9

Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelines.

Ost P, De Meerleer G, Vercauteren T, De Gersem W, Veldeman L, Vandecasteele K, Fonteyne V, Villeirs G. Ost P, et al. Among authors: de gersem w, de meerleer g. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e143-9. doi: 10.1016/j.ijrobp.2010.12.057. Epub 2011 Mar 4. Int J Radiat Oncol Biol Phys. 2011. PMID: 21377287

10

The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397).

Barnett GC, De Meerleer G, Gulliford SL, Sydes MR, Elliott RM, Dearnaley DP. Barnett GC, et al. Among authors: de meerleer g. Clin Oncol (R Coll Radiol). 2011 Nov;23(9):613-24. doi: 10.1016/j.clon.2011.03.001. Epub 2011 Apr 5. Clin Oncol (R Coll Radiol). 2011. PMID: 21470834 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters